Essential Hypertension: 824 Clinical Trials, Page 1 of 83

1 2 3 4 5 …10 15 20 … »Last Page »

Hide Studies Not Open or Pending

Efficacy and Safety of Mexartan Potassium Tablets (AZL-M) and Calcium Channel Blockers (CCB) in the Treatment of Adults With Essential Hypertension in Chinese Population: a National Multicenter, Prospective, Observational Study

Condition(s):Essential HypertensionLast Updated:July 24, 2023Not yet recruiting

Safety and Efficacy of Remote Ischemic Conditioning in Patients With Essential Hypertension (SERIC-EH)

Condition(s):Essential HypertensionLast Updated:November 2, 2022Not yet recruiting

Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka^® Fixed Combination in Patients With Essential Hypertension

Condition(s):Essential HypertensionLast Updated:May 1, 2012Completed

Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential Hypertension

Condition(s):Essential HypertensionLast Updated:November 12, 2020Unknown status

Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomera™ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension

Condition(s):Essential HypertensionLast Updated:April 10, 2014Completed

A Study for Post-Marketing Surveillance of Azilsartan Medoxomil in the Treatment of Adult Participants With Essential Hypertension in South Korea

Condition(s):Essential HypertensionLast Updated:July 21, 2020Unknown status

s086 Tablets in the Treatment of Mild to Moderate Essential Hypertension

Condition(s):Essential HypertensionLast Updated:September 5, 2021Unknown status

A Study for Post-marketing Surveillance of Azilsartan Medoxomil/Chlorthalidone Fixed Dose Combination (FDC) in the Treatment of Participants With Essential Hypertension in South Korea

Condition(s):Essential HypertensionLast Updated:July 22, 2020Unknown status

Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

Condition(s):Essential HypertensionLast Updated:December 21, 2018Completed

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Asian Patients With Essential Hypertension

Condition(s):Essential HypertensionLast Updated:December 29, 2016Completed

1 2 3 4 5 …10 15 20 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.